156 related articles for article (PubMed ID: 22297468)
1. Favorable outcome associated with an IGF-1 ligand signature in breast cancer.
Mu L; Tuck D; Katsaros D; Lu L; Schulz V; Perincheri S; Menato G; Scarampi L; Harris L; Yu H
Breast Cancer Res Treat; 2012 May; 133(1):321-31. PubMed ID: 22297468
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
Chong KY; Subramanian A; Mokbel K; Sharma AK
J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260
[TBL] [Abstract][Full Text] [Related]
3. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
[TBL] [Abstract][Full Text] [Related]
4. A gene transcription signature of obesity in breast cancer.
Creighton CJ; Sada YH; Zhang Y; Tsimelzon A; Wong H; Dave B; Landis MD; Bear HD; Rodriguez A; Chang JC
Breast Cancer Res Treat; 2012 Apr; 132(3):993-1000. PubMed ID: 21750966
[TBL] [Abstract][Full Text] [Related]
5. Favorable prognostic value of SOCS2 and IGF-I in breast cancer.
Haffner MC; Petridou B; Peyrat JP; Révillion F; Müller-Holzner E; Daxenbichler G; Marth C; Doppler W
BMC Cancer; 2007 Jul; 7():136. PubMed ID: 17651480
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression.
Fu P; Ibusuki M; Yamamoto Y; Hayashi M; Murakami K; Zheng S; Iwase H
Breast Cancer Res Treat; 2011 Nov; 130(1):307-17. PubMed ID: 21748295
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival.
Shin A; Ren Z; Shu XO; Cai Q; Gao YT; Zheng W
Breast Cancer Res Treat; 2007 Sep; 105(1):55-61. PubMed ID: 17066319
[TBL] [Abstract][Full Text] [Related]
8. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
Powe DG; Voss MJ; Habashy HO; Zänker KS; Green AR; Ellis IO; Entschladen F
Breast Cancer Res Treat; 2011 Nov; 130(2):457-63. PubMed ID: 21298476
[TBL] [Abstract][Full Text] [Related]
9. Expression of insulin-like growth factor II in female breast cancer as related to established prognostic factors and long-term prognosis.
Toropainen EM; Lipponen PK; Syrjanen KJ
Anticancer Res; 1995; 15(6B):2669-74. PubMed ID: 8669844
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.
Yerushalmi R; Gelmon KA; Leung S; Gao D; Cheang M; Pollak M; Turashvili G; Gilks BC; Kennecke H
Breast Cancer Res Treat; 2012 Feb; 132(1):131-42. PubMed ID: 21574055
[TBL] [Abstract][Full Text] [Related]
11. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
12. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
13. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
14. Population-based molecular prognosis of breast cancer by transcriptional profiling.
Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
[TBL] [Abstract][Full Text] [Related]
15. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
Grönberg M; Fjällskog ML; Jirström K; Janson ET
Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
[TBL] [Abstract][Full Text] [Related]
16. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
[TBL] [Abstract][Full Text] [Related]
17. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
18. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.
Peurala E; Koivunen P; Bloigu R; Haapasaari KM; Jukkola-Vuorinen A
Breast Cancer Res Treat; 2012 May; 133(1):179-88. PubMed ID: 21877141
[TBL] [Abstract][Full Text] [Related]
19. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.
Schoppmann SF; Berghoff A; Dinhof C; Jakesz R; Gnant M; Dubsky P; Jesch B; Heinzl H; Birner P
Breast Cancer Res Treat; 2012 Jul; 134(1):237-44. PubMed ID: 22350732
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
Furukawa M; Raffeld M; Mateo C; Sakamoto A; Moody TW; Ito T; Venzon DJ; Serrano J; Jensen RT
Clin Cancer Res; 2005 May; 11(9):3233-42. PubMed ID: 15867218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
